What is the initial (starting) dose of Cosentyx?
Cosentyx (secukinumab) initial dosing depends on the condition being treated. Common adult regimens start with a loading schedule.
For plaque psoriasis (adult), the usual start is:
- 300 mg by injection at weeks 0, 1, 2, and 3, then
- 300 mg every 4 weeks after that.
For psoriatic arthritis (adult), the usual start is:
- 150 mg or 300 mg at weeks 0, 1, and 2, then
- maintenance based on response/label guidance.
For ankylosing spondylitis, the usual start is:
- 150 mg (or sometimes 300 mg depending on indication and label specifics), typically at week 0, then
- every 4 weeks.
What dose strength do patients start with: 150 mg or 300 mg?
Cosentyx is available in 150 mg and 300 mg dosing formats, and the starting dose is usually 300 mg for plaque psoriasis, while psoriatic arthritis and other inflammatory conditions may start at 150 mg or 300 mg depending on the specific diagnosis and patient factors.
How is it given during the first month?
Most “initial dose” schedules are designed as a loading phase over the first few weeks (commonly weeks 0–3 for plaque psoriasis). After the loading phase, dosing typically shifts to a steadier interval (often every 4 weeks).
Which form matters: prefilled pen vs syringe?
The dose schedule is the same regardless of whether you use the prefilled pen or prefilled syringe; what changes is how the prescribed dose is delivered (number of injections to reach 150 mg vs 300 mg). The key is following the prescribed mg and week-by-week timing.
Quick check: which condition are you asking about?
Cosentyx dosing differs by indication. If you tell me which you mean (for example, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis), I can state the exact starting dose schedule for that condition.